JPH025098B2 - - Google Patents
Info
- Publication number
- JPH025098B2 JPH025098B2 JP60250845A JP25084585A JPH025098B2 JP H025098 B2 JPH025098 B2 JP H025098B2 JP 60250845 A JP60250845 A JP 60250845A JP 25084585 A JP25084585 A JP 25084585A JP H025098 B2 JPH025098 B2 JP H025098B2
- Authority
- JP
- Japan
- Prior art keywords
- adsorbent
- rheumatoid factor
- crosslinking agent
- aromatic ring
- container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003463 adsorbent Substances 0.000 claims description 40
- 238000001179 sorption measurement Methods 0.000 claims description 26
- 229920002554 vinyl polymer Polymers 0.000 claims description 18
- -1 vinyl compound Chemical class 0.000 claims description 17
- 125000003118 aryl group Chemical group 0.000 claims description 16
- 239000003431 cross linking reagent Substances 0.000 claims description 16
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 11
- 229920001577 copolymer Polymers 0.000 claims description 11
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- KKFHAJHLJHVUDM-UHFFFAOYSA-N n-vinylcarbazole Chemical compound C1=CC=C2N(C=C)C3=CC=CC=C3C2=C1 KKFHAJHLJHVUDM-UHFFFAOYSA-N 0.000 claims description 6
- KOMNUTZXSVSERR-UHFFFAOYSA-N 1,3,5-tris(prop-2-enyl)-1,3,5-triazinane-2,4,6-trione Chemical group C=CCN1C(=O)N(CC=C)C(=O)N(CC=C)C1=O KOMNUTZXSVSERR-UHFFFAOYSA-N 0.000 claims description 5
- POSICDHOUBKJKP-UHFFFAOYSA-N prop-2-enoxybenzene Chemical compound C=CCOC1=CC=CC=C1 POSICDHOUBKJKP-UHFFFAOYSA-N 0.000 claims description 4
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 2
- 239000005977 Ethylene Substances 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- 210000002381 plasma Anatomy 0.000 description 17
- 239000003446 ligand Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 210000001124 body fluid Anatomy 0.000 description 7
- 239000010839 body fluid Substances 0.000 description 7
- 210000000601 blood cell Anatomy 0.000 description 6
- 108010074605 gamma-Globulins Proteins 0.000 description 6
- 102000009027 Albumins Human genes 0.000 description 5
- 108010088751 Albumins Proteins 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229920002689 polyvinyl acetate Polymers 0.000 description 4
- 239000011118 polyvinyl acetate Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 229940098197 human immunoglobulin g Drugs 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000010557 suspension polymerization reaction Methods 0.000 description 2
- BJELTSYBAHKXRW-UHFFFAOYSA-N 2,4,6-triallyloxy-1,3,5-triazine Chemical compound C=CCOC1=NC(OCC=C)=NC(OCC=C)=N1 BJELTSYBAHKXRW-UHFFFAOYSA-N 0.000 description 1
- KXYAVSFOJVUIHT-UHFFFAOYSA-N 2-vinylnaphthalene Chemical compound C1=CC=CC2=CC(C=C)=CC=C21 KXYAVSFOJVUIHT-UHFFFAOYSA-N 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000004023 fresh frozen plasma Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 125000003011 styrenyl group Chemical group [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60250845A JPS62112562A (ja) | 1985-11-11 | 1985-11-11 | リウマチ因子の吸着材および吸着装置 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60250845A JPS62112562A (ja) | 1985-11-11 | 1985-11-11 | リウマチ因子の吸着材および吸着装置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62112562A JPS62112562A (ja) | 1987-05-23 |
| JPH025098B2 true JPH025098B2 (fr) | 1990-01-31 |
Family
ID=17213864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60250845A Granted JPS62112562A (ja) | 1985-11-11 | 1985-11-11 | リウマチ因子の吸着材および吸着装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62112562A (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5027591B2 (ja) * | 2006-08-18 | 2012-09-19 | 株式会社カネカ | 架橋ポリマー粒子およびその製法 |
| CN103611504B (zh) * | 2013-11-26 | 2015-10-28 | 重庆大学 | 一种用于血液灌流去除类风湿因子的吸附材料及其制备方法 |
-
1985
- 1985-11-11 JP JP60250845A patent/JPS62112562A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62112562A (ja) | 1987-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6416487B1 (en) | Method of removing beta-2 microglobulin from blood | |
| US11020521B2 (en) | Hemocompatibility modifiers for cross-linked polymeric material | |
| EP0056977B1 (fr) | Adsorbant pour anticorps et complexes d'immunisation, dispositif d'adsorption et appareil de purification du sang | |
| US4627915A (en) | Absorbent of autoantibody and immune complexes, adsorbing device and blood purifying apparatus comprising the same | |
| FR2480606A1 (fr) | ||
| JPS6145773A (ja) | 体液浄化材 | |
| JPH04187206A (ja) | 白血球分離装置及び白血球分離材料の製造方法 | |
| JPH025098B2 (fr) | ||
| US20070077555A1 (en) | Adsorption system for the removal of viruses and viral components from fluids, in particular blood and blood plasma | |
| JPH0977790A (ja) | 糖脂質抗体吸着材 | |
| Yilmaz et al. | Specific adsorption of the autoantibodies from rheumatoid arthritis patient plasma using histidine-containing affinity beads | |
| JPS6087854A (ja) | 血液浄化吸着材 | |
| JPH0245064A (ja) | インターロイキン２レセプターの除去装置およびそれを備えた血液体外循環装置 | |
| JP2568846B2 (ja) | ミオグロビン吸着材 | |
| JPH0236878A (ja) | ヒト免疫不全症候群ウイルスおよび／またはその関連物質除去剤 | |
| JPH0316639A (ja) | 吸着体およびそれを用いた除去装置 | |
| JPS61253071A (ja) | 血液浄化用装置 | |
| JPH0254747B2 (fr) | ||
| JPS5861752A (ja) | 悪性物質の吸着材 | |
| JPS62244442A (ja) | 低比重リポ蛋白質吸着材およびその製造方法 | |
| JPS59139937A (ja) | 低比重リポ蛋白吸着材 | |
| JPS59189859A (ja) | 自己抗体、免疫複合体を吸着する材料 | |
| JPH0534024B2 (fr) | ||
| JPS59186560A (ja) | 自己抗体、免疫複合体の吸着材 | |
| JPH0232897B2 (fr) |